Eric David Peterson, MD

Professor of Medicine
Fred Cobb, M.D. Distinguished Professor of Medicine
Core Faculty Member, Duke-Margolis Center for Health Policy
Member in the Duke Clinical Research Institute
Campus mail 200 Morris Street, Durham, NC 27701
Phone (919) 668-8830
Email address

Dr Peterson is the Fred Cobb Distinguished Professor of Medicine in the Division of Cardiology, a DukeMed Scholar, and the Past Executive Director of the Duke Clinical Research Institute (DCRI), Durham, NC, USA.

Dr Peterson is the Principal Investigator of the National Institute of Health, Lung and Blood Institute (NHLBI) Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction (SPIRRIT) Trial  He is also the Principal Investigator of the Data Coordinating Centers for the Society of Thoracic Surgeons (STS), National Cardiac Surgery Database, the American College of Cardiology National Cardiac Database (ACC-NCDR) and the American Heart Association Get With the Guidelines Database (AHA-GWTG).  Dr Peterson also oversees multiple industry sponsored clinical studies.

Additionally, Dr Peterson serves on multiple national committees and guideline and performance measure development groups. Dr Peterson is a member of the American Society for Clinical Investigation (ASCI), the Association of American Physicians (AAP), and the Association of University Cardiologists (AUC).

Since 2013, Dr Peterson has been voted one of world’s top 400 most influential researchers in biomedicine. as well as named by Thomson Reuters as a ‘Highly Cited Researcher’, ranking him among the top 1% most cited in clinical medicine. He is a Contributing Editor on the Journal of the American Medical Association and is a recognized leader in outcomes and quality research with over 1200 peer-reviewed publications in the field.

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 1992 - 1995
  • Fellow in General Internal Medicine, Medicine, Harvard University , 1991 - 1992
  • Medical Resident, Medicine, Children's Hospital, Boston, 1988 - 1991
  • M.D., University of Pittsburgh, 1988


Shaw, L. J., E. D. Peterson, L. K. Shaw, K. L. Kesler, E. R. DeLong, F. E. Harrell, L. H. Muhlbaier, and D. B. Mark. “Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups.” Circulation 98, no. 16 (October 20, 1998): 1622–30.

Full Text

Peterson, E. D., E. R. DeLong, J. G. Jollis, L. H. Muhlbaier, and D. B. Mark. “The effects of New York's bypass surgery provider profiling on access to care and patient outcomes in the elderly.” Journal of the American College of Cardiology 32, no. 4 (October 1998): 993–99.

Full Text

Block, P. C., E. D. Peterson, R. Krone, K. Kesler, E. Hannan, G. T. O’Connor, and K. Detre. “Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection.” Journal of the American College of Cardiology 32, no. 1 (July 1998): 275–82.

Full Text

Hathaway, W. R., E. D. Peterson, G. S. Wagner, C. B. Granger, K. M. Zabel, K. S. Pieper, K. A. Clark, L. H. Woodlief, and R. M. Califf. “Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.” Jama 279, no. 5 (February 4, 1998): 387–91.

Full Text

DeLong, E. R., E. D. Peterson, D. M. DeLong, L. H. Muhlbaier, S. Hackett, and D. B. Mark. “Comparing risk-adjustment methods for provider profiling.” Stat Med 16, no. 23 (December 15, 1997): 2645–64.<2645::aid-sim696>;2-d.

Full Text

O’Brien, J. E., E. D. Peterson, and G. P. Keeler. “How does estrogen affect outcome in postmenopausal women undergoing percutaneous coronary procedures?” Consultant 37, no. 3 (December 1, 1997): 674.


Alexander, K. P., and E. D. Peterson. “Coronary artery bypass grafting in the elderly.” American Heart Journal 134, no. 5 Pt 1 (November 1997): 856–64.

Full Text